Kimia Biosciences Ltd

KIMIABL

Watchlist

AI Mode

‌

Market Cap

₹ 155 Cr

P/E

18.88

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

HIGH MARGIN

Technicals

Bearish

Risk

HIGH RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Kimia Bio-sciences Limited, formerly known as Laurel Organics Limited, focuses on manufacturing bulk drugs and APIs at its plant in Gurgaon, Haryana.

The company faced financial difficulties and was declared a sick unit during 1998-99, but later recovered and moved out of the BIFR purview by 2005.

In 2018, Kimia Biosciences Limited underwent a reverse merger with its holding company, which was holding a majority equity stake.

Kimia has maintained its strategic focus on pharmaceuticals, particularly in manufacturing and supplying APIs, strengthening its market position.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs

Market Cap

155 Cr

Volatility

High Risk

P/E Ratio

18.9

Industry P/E

59.2

PEG Ratio

0.1

P/B Ratio

13.3

52W High

86.85

52W Low

26.09

Sales CAGR

13.39%

-1.62%

2.27%

10Y

104.26%

Profit CAGR

280.98%

—

47.41%

10Y

—

ROE

TTM

70.62%

-32.03%

-7.43%

10Y

-2.77%

ROCE

TTM

33.57%

7.55%

7.42%

10Y

7.05%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
PANCHSHEEL	128.50	172 Cr	13.97	1.24	0.61	8.89	11.28	7.20
ASTONEALAB	160.00	168 Cr	31.43	3.00	0.00	8.67	10.26	3.81
AUROLAB	252.80	161 Cr	87.81	3.76	0.00	4.47	7.31	1.55
KIMIABL	32.00	155 Cr	18.88	13.34	0.00	70.62	33.57	8.06
KREBSBIO	69.88	151 Cr	—	0.00	0.00	17.42	-19.17	-16.35
LACTOSE	113.00	145 Cr	32.09	2.32	0.00	7.24	10.49	3.28
SMRUTHIORG	122.05	139 Cr	29.83	1.97	1.23	6.60	10.56	4.69

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	24	24	26	30	22	28	30	38	24	34
Expenses	26	26	27	26	19	25	25	30	21	31
Operating Profit	-1.64	-1.96	-1.05	4.16	3.71	3.37	5.00	8.18	2.53	2.52
OPM %	-6.77	-8.10	-4.02	13.73	16.56	11.96	16.61	21.39	10.73	7.41
Other Income	0.13	0.64	0.58	0.30	0.08	0.37	0.42	0.44	0.85	-0.33
Interest	1.28	1.12	1.31	1.34	1.11	1.04	1.01	1.40	1.75	0.27
Depreciation	0.83	0.82	0.82	0.82	0.90	0.79	0.82	0.88	0.94	0.97
Profit Before Tax	-3.62	-3.27	-2.60	2.31	1.78	1.91	3.60	6.34	0.69	0.95
Tax %	25.14	25.08	25.00	22.08	19.66	15.71	-26.94	68.61	13.04	-7.37
Net Profit	-2.71	-2.44	-1.95	1.80	1.44	1.61	4.57	1.99	0.60	1.02
EPS in Rs	-0.57	-0.52	-0.41	0.38	0.30	0.34	0.97	0.42	0.13	0.21

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	1.46	76	94	106	133	125	129	105	119	120
Expenses	2.44	74	88	102	124	124	133	105	99	101
Operating Profit	-0.98	2.47	5.57	4.45	8.38	0.63	-4.98	-0.48	20	19
OPM %	-67.18	3.23	5.93	4.19	6.31	0.51	-3.87	-0.46	17.03	15.89
Other Income	0.59	0.86	1.33	0.96	2.46	0.93	0.17	1.64	1.32	2.08
Interest	0.27	0.58	2.00	2.53	3.39	3.64	4.25	5.05	4.56	5.20
Depreciation	0.35	1.14	1.10	1.66	1.91	2.94	3.33	3.29	3.38	3.43
Profit Before Tax	-1.01	1.60	3.81	1.23	5.53	-5.02	-12	-7.18	14	13
Tax %	7.57	-3.82	-1.30	-12.65	7.77	26.21	24.51	26.10	29.50	30.06
Net Profit	-0.93	1.67	3.86	1.38	5.10	-3.70	-9.35	-5.31	9.61	8.77
EPS in Rs	-0.20	0.09	0.58	0.44	1.08	-0.78	-1.98	-1.12	2.03	1.73
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	7.39	7.39	1.46	1.46	4.64	4.73	4.73	4.73	4.73	4.73
Reserves	-11	-12	0.18	4.00	8.64	14	10	0.73	-4.40	5.23
Borrowings	6.75	8.83	30	30	31	45	41	53	44	33
Other Liabilities	1.24	7.53	27	30	42	43	54	63	56	68
Total Liabilities	4.11	12	58	65	86	107	109	121	100	111
Fixed Assets	3.20	6.66	13	16	18	28	35	34	32	33
CWIP	0.00	3.07	2.48	1.53	5.74	5.77	0.00	0.61	0.58	0.00
Investments	0.00	0.00	0.00	0.01	0.42	0.06	0.06	0.06	0.00	0.00
Other Assets	0.90	2.02	43	48	62	72	74	87	68	78
Total Assets	4.11	12	58	65	86	107	109	121	100	111

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-5.99	-0.74	-7.09	-2.65	0.31	5.97	8.00	-6.77	15	21
Cash from Investing Activity	-0.10	-6.23	-2.36	-2.22	-8.63	-14	-0.71	-2.80	-1.49	-4.70
Cash from Financing Activity	6.09	7.01	9.91	4.42	8.46	7.99	-7.67	9.54	-13	-17
Net Cash Flow	0.01	0.04	0.46	-0.46	0.14	0.35	-0.38	-0.03	-0.03	0.06

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%
Public	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%
Total Shareholders	12,243	12,201	12,147	12,118	12,063	12,110	12,023	12,179	12,231	12,278	12,200	12,616

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Oscillators

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	24	24	26	30	22	28	30	38	24	34
Expenses	26	26	27	26	19	25	25	30	21	31
Operating Profit	-1.64	-1.96	-1.05	4.16	3.71	3.37	5.00	8.18	2.53	2.52
OPM %	-6.77	-8.10	-4.02	13.73	16.56	11.96	16.61	21.39	10.73	7.41
Other Income	0.13	0.64	0.58	0.30	0.08	0.37	0.42	0.44	0.85	-0.33
Interest	1.28	1.12	1.31	1.34	1.11	1.04	1.01	1.40	1.75	0.27
Depreciation	0.83	0.82	0.82	0.82	0.90	0.79	0.82	0.88	0.94	0.97
Profit Before Tax	-3.62	-3.27	-2.60	2.31	1.78	1.91	3.60	6.34	0.69	0.95
Tax %	25.14	25.08	25.00	22.08	19.66	15.71	-26.94	68.61	13.04	-7.37
Net Profit	-2.71	-2.44	-1.95	1.80	1.44	1.61	4.57	1.99	0.60	1.02
EPS in Rs	-0.57	-0.52	-0.41	0.38	0.30	0.34	0.97	0.42	0.13	0.21

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	1.46	76	94	106	133	125	129	105	119	120
Expenses	2.44	74	88	102	124	124	133	105	99	101
Operating Profit	-0.98	2.47	5.57	4.45	8.38	0.63	-4.98	-0.48	20	19
OPM %	-67.18	3.23	5.93	4.19	6.31	0.51	-3.87	-0.46	17.03	15.89
Other Income	0.59	0.86	1.33	0.96	2.46	0.93	0.17	1.64	1.32	2.08
Interest	0.27	0.58	2.00	2.53	3.39	3.64	4.25	5.05	4.56	5.20
Depreciation	0.35	1.14	1.10	1.66	1.91	2.94	3.33	3.29	3.38	3.43
Profit Before Tax	-1.01	1.60	3.81	1.23	5.53	-5.02	-12	-7.18	14	13
Tax %	7.57	-3.82	-1.30	-12.65	7.77	26.21	24.51	26.10	29.50	30.06
Net Profit	-0.93	1.67	3.86	1.38	5.10	-3.70	-9.35	-5.31	9.61	8.77
EPS in Rs	-0.20	0.09	0.58	0.44	1.08	-0.78	-1.98	-1.12	2.03	1.73
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	7.39	7.39	1.46	1.46	4.64	4.73	4.73	4.73	4.73	4.73
Reserves	-11	-12	0.18	4.00	8.64	14	10	0.73	-4.40	5.23
Borrowings	6.75	8.83	30	30	31	45	41	53	44	33
Other Liabilities	1.24	7.53	27	30	42	43	54	63	56	68
Total Liabilities	4.11	12	58	65	86	107	109	121	100	111
Fixed Assets	3.20	6.66	13	16	18	28	35	34	32	33
CWIP	0.00	3.07	2.48	1.53	5.74	5.77	0.00	0.61	0.58	0.00
Investments	0.00	0.00	0.00	0.01	0.42	0.06	0.06	0.06	0.00	0.00
Other Assets	0.90	2.02	43	48	62	72	74	87	68	78
Total Assets	4.11	12	58	65	86	107	109	121	100	111

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-5.99	-0.74	-7.09	-2.65	0.31	5.97	8.00	-6.77	15	21
Cash from Investing Activity	-0.10	-6.23	-2.36	-2.22	-8.63	-14	-0.71	-2.80	-1.49	-4.70
Cash from Financing Activity	6.09	7.01	9.91	4.42	8.46	7.99	-7.67	9.54	-13	-17
Net Cash Flow	0.01	0.04	0.46	-0.46	0.14	0.35	-0.38	-0.03	-0.03	0.06

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
PANCHSHEEL	128.50	172 Cr	13.97	1.24	0.61	8.89	11.28	7.20
ASTONEALAB	160.00	168 Cr	31.43	3.00	0.00	8.67	10.26	3.81
AUROLAB	252.80	161 Cr	87.81	3.76	0.00	4.47	7.31	1.55
KIMIABL	32.00	155 Cr	18.88	13.34	0.00	70.62	33.57	8.06
KREBSBIO	69.88	151 Cr	—	0.00	0.00	17.42	-19.17	-16.35
LACTOSE	113.00	145 Cr	32.09	2.32	0.00	7.24	10.49	3.28
SMRUTHIORG	122.05	139 Cr	29.83	1.97	1.23	6.60	10.56	4.69

Overview

Detailed Summary

Kimia Bio-sciences Limited, formerly known as Laurel Organics Limited, focuses on manufacturing bulk drugs and APIs at its plant in Gurgaon, Haryana.

The company faced financial difficulties and was declared a sick unit during 1998-99, but later recovered and moved out of the BIFR purview by 2005.

In 2018, Kimia Biosciences Limited underwent a reverse merger with its holding company, which was holding a majority equity stake.

Kimia has maintained its strategic focus on pharmaceuticals, particularly in manufacturing and supplying APIs, strengthening its market position.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs

Market Cap

155 Cr

Volatility

High Risk

P/E Ratio

18.9

Industry P/E

59.2

PEG Ratio

0.1

P/B Ratio

13.3

52W High

86.85

52W Low

26.09

Sales CAGR

13.39%

-1.62%

2.27%

10Y

104.26%

Profit CAGR

280.98%

—

47.41%

10Y

—

ROE

TTM

70.62%

-32.03%

-7.43%

10Y

-2.77%

ROCE

TTM

33.57%

7.55%

7.42%

10Y

7.05%